Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$58.58
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | MRK Avg Daily Volume: 10,820,900
Last Update: 03/02/15 - 4:02 PM EST
Volume: 0
YTD Performance: 3.15%
Open: $0.00
Previous Close: $58.58
52 Week Range: $52.49 - $63.62
Oustanding Shares: 2,850,873,371
Market Cap: 166,890,127,138
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 7 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.08 2.00 2.00 2.00
Latest Dividend: 0.45
Latest Dividend Yield: 3.07%
Dividend Ex-Date: 03/12/15
Price Earnings Ratio: 14.38
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
14.38 14.40 26.45
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.62% 2.79% 54.44%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.12 -0.04
Net Income 164.20 0.87 0.23
EPS 176.90 1.05 0.27
Earnings for MRK:
EBITDA 6.68B
Revenue 42.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.78 $0.82 $3.42 $3.88
Number of Analysts 6 6 10 10
High Estimate $0.82 $0.87 $3.55 $4.10
Low Estimate $0.73 $0.75 $3.34 $3.48
Prior Year $0.88 $0.85 $3.49 $3.42
Growth Rate (Year over Year) -11.55% -4.12% -1.86% 13.17%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Update
Mar 03, 2015 | 5:09 AM EST
Cowen Health Care Conference (Day 2 of 3) - 03/02/15 - 03/04/15 Boston, MA
Bearish
Feb 05, 2015 | 8:00 AM EST
MRK estimates were cut through 2016, BMO Capital said. Company is facing significant growth headwinds. Market Perform rating and new $6...
Use the overall weakness to pick up the America First stocks.
Low P/E multiples just aren't any protection.
Watch the share count when looking at earnings.
Try these stocks for dividend income instead.
Corporate fundamentals begin to matter. 
The next 10 Dow components in my analysis.
Bullish
Jan 05, 2015 | 8:19 AM EST
MRK was upgraded from Market Perform to Outperform, Bernstein said. $68 price target. Keytruda could be launched up to a year earlier t...

Rise of the Dogs of the Dow Real Money Pro($)

Every dog has its day.

Columnist Conversations

Bullishness is back for emerging markets, according to a survey carried out in February. February's bullish re...
Nails a couple of oils that are in deep trouble; must read
After the close Oak announced a 4 million share offering and the shares are getting hit down to $50.10. I am n...
Very solid day to start March as equities tack on to their gains from February. Appreciate the shout out from ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.